SAVIENT PHARMACEUTICALS INC (SVNT) is a publicly traded company in the Unknown sector. Across all available filings, 39 corporate insiders have executed 566 transactions totaling $13.9M, demonstrating a bearish sentiment with -$13.0M in net insider flow. The most recent transaction on Mar 31, 2017 involved a transaction of 7,747 shares valued at $331.0K.
No significant insider buying has been recorded for SVNT in the recent period.
No significant insider selling has been recorded for SVNT in the recent period.
Based on recent SEC filings, insider sentiment for SVNT is bearish with an Insider Alignment Score of 3/100 and a net flow of -$13.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at SAVIENT PHARMACEUTICALS INC (SVNT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 39 insiders are actively trading SVNT stock, having executed 566 transactions in the past 90 days. The most active insider is Christopher G. Clement (Executive), who has made 47 transactions totaling $5.1M.
Get notified when executives and directors at SVNT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 31, 2017 | Blanchard Karl | Executive | Payment | 7,747 | $42.73 | $331.0K | |
| Mar 31, 2017 | Minmier James | Executive | Payment | 4,448 | $42.73 | $190.1K | |
| Mar 31, 2017 | D. Baetz Cary | Executive | Payment | 7,747 | $42.73 | $331.0K | |
| Mar 31, 2017 | L. Winchester Jerry | Executive | Payment | 12,911 | $42.73 | $551.7K | Large |
| Mar 31, 2017 | Stanger William | Executive | Payment | 3,559 | $42.73 | $152.1K | |
| Dec 31, 2016 | Blanchard Karl | Executive | Payment | 7,747 | $45.00 | $348.6K | |
| Dec 31, 2016 | L. Winchester Jerry | Executive | Payment | 12,911 | $45.00 | $581.0K | Large |
| Dec 31, 2016 | Minmier James | Executive | Payment | 6,456 | $45.00 | $290.5K | |
| Dec 31, 2016 | D. Baetz Cary | Executive | Payment | 7,747 | $45.00 | $348.6K | |
| Dec 31, 2016 | Stanger William | Executive | Payment | 5,165 | $45.00 | $232.4K | |
| Sep 23, 2016 | L. Winchester Jerry | Executive | Award | 440,000 | $N/A | $0 | |
| Sep 23, 2016 | L. Winchester Jerry | Executive | Payment | 51,645 | $17.31 | $894.0K | Large |
| Sep 23, 2016 | S. King David | Executive | Award | 12,998 | $N/A | $0 | |
| Sep 23, 2016 | John Dipaolo Edward | Executive | Award | 12,998 | $N/A | $0 | |
| Sep 23, 2016 | Stanger William | Executive | Payment | 18,129 | $17.31 | $313.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 187 | $18.4M | 43.8% |
Sale(S) | 234 | $13.5M | 32.0% |
Payment(F) | 27 | $7.9M | 18.8% |
Exercise(M) | 89 | $1.8M | 4.2% |
Purchase(P) | 25 | $470.9K | 1.1% |
Small Acquisition(L) | 1 | $9.4K | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insider selling pressure at SAVIENT PHARMACEUTICALS INC has increased, with 39 insiders executing 566 transactions across all time. Total sales of $13.5M significantly outpace purchases of $470.9K, resulting in a net outflow of $13.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.